loadpatents
name:-0.021520137786865
name:-0.017804145812988
name:-0.013293981552124
MALAGU; KARINE FABIENNE Patent Filings

MALAGU; KARINE FABIENNE

Patent Applications and Registrations

Patent applications and USPTO patent grants for MALAGU; KARINE FABIENNE.The latest application filed is for "thiophene derivatives as antiviral agents".

Company Profile
17.21.30
  • MALAGU; KARINE FABIENNE - CAMBRIDGE GB
  • Malagu; Karine Fabienne - Saffron Walden GB
  • Malagu; Karine Fabienne - Saffron GB
  • Malagu; Karine Fabienne - Macclesfield GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Thiophene Derivatives As Antiviral Agents
App 20220213053 - MELDRUM; ERIC ;   et al.
2022-07-07
Thiophene derivatives as antiviral agents
Grant 11,279,683 - Meldrum , et al. March 22, 2
2022-03-22
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20210238159 - Altenbach; Robert J. ;   et al.
2021-08-05
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,988,454 - Altenbach , et al. April 27, 2
2021-04-27
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,981,890 - Altenbach , et al. April 20, 2
2021-04-20
Non-fused Thiophene Derivatives And Their Uses
App 20210040059 - MELDRUM; ERIC ;   et al.
2021-02-11
Fused Thiophene Derivatives And Their Uses
App 20200369682 - MELDRUM; ERIC ;   et al.
2020-11-26
Non-fused Thiophene Derivatives And Their Uses
App 20200369655 - MELDRUM; ERIC ;   et al.
2020-11-26
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,042 - Altenbach , et al. November 24, 2
2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,041 - Altenbach , et al. November 24, 2
2020-11-24
Fused Thiophene Derivatives And Their Uses
App 20200361924 - MELDRUM; ERIC ;   et al.
2020-11-19
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,829,473 - Altenbach , et al. November 10, 2
2020-11-10
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277274 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277276 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277273 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use
App 20200277275 - Altenbach; Robert J. ;   et al.
2020-09-03
Thiophene Derivatives As Antiviral Agents
App 20190352275 - MELDRUM; ERIC ;   et al.
2019-11-21
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,428,017 - Altenbach , et al. October 1, 2
2019-10-01
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 10,307,422 - Burli , et al.
2019-06-04
Substituted Tricyclics and Method of Use
App 20190135827 - Altenbach; Robert J. ;   et al.
2019-05-09
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20190077784 - Altenbach; Robert J. ;   et al.
2019-03-14
Modulators of cystic fibrosis transmembrane conductance regulator protein
Grant 10,118,916 - Altenbach , et al. November 6, 2
2018-11-06
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244611 - Altenbach; Robert J. ;   et al.
2018-08-30
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244640 - Altenbach; Robert J. ;   et al.
2018-08-30
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
Grant 10,034,884 - Duggan , et al. July 31, 2
2018-07-31
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20180207159 - BURLI; Roland Werner ;   et al.
2018-07-26
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,925,187 - Burli , et al. March 27, 2
2018-03-27
Substituted Tricyclics and Method of Use
App 20180037587 - Altenbach; Robert J. ;   et al.
2018-02-08
Substituted tricyclics and method of use
Grant 9,840,513 - Altenbach , et al. December 12, 2
2017-12-12
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein
App 20170305891 - Altenbach; Robert J. ;   et al.
2017-10-26
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,783,545 - Burli , et al. October 10, 2
2017-10-10
Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors
App 20170281637 - Duggan; Heather Mary Ellen ;   et al.
2017-10-05
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
Grant 9,717,736 - Duggan , et al. August 1, 2
2017-08-01
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20170143718 - BURLI; Roland Werner ;   et al.
2017-05-25
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,549,910 - Burli , et al. January 24, 2
2017-01-24
Substituted Tricyclics And Method Of Use
App 20170015675 - Altenbach; Robert J. ;   et al.
2017-01-19
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20160272647 - BURLI; Roland Werner ;   et al.
2016-09-22
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome
Grant 9,371,332 - Burli , et al. June 21, 2
2016-06-21
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20160158172 - BURLI; Roland Werner ;   et al.
2016-06-09
Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors
App 20160067258 - Duggan; Heather Mary Ellen ;   et al.
2016-03-10
Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome
Grant 9,260,381 - Burli , et al. February 16, 2
2016-02-16
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
Grant 9,227,976 - Burli , et al. January 5, 2
2016-01-05
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20150265617 - BURLI; Roland Werner ;   et al.
2015-09-24
Pyrazolopyridazines And Methods For Treating Retinal Degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20150266812 - BURLI; Roland Werner ;   et al.
2015-09-24
Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
Grant 9,102,670 - Duggan , et al. August 11, 2
2015-08-11
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
Grant 9,079,909 - Burli , et al. July 14, 2
2015-07-14
Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome
Grant 8,765,762 - Burli , et al. July 1, 2
2014-07-01
Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors
App 20140135315 - DUGGAN; Heather Mary Ellen ;   et al.
2014-05-15
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20140121197 - BURLI; Roland Werner ;   et al.
2014-05-01
Pyrazolopyridazines And Methods For Treating Retinal-degerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20140121205 - Burli; Roland Werner ;   et al.
2014-05-01
Pyrazolopyridazines And Methods For Treating Retinal-degenerative Diseases And Hearing Loss Associated With Usher Syndrome
App 20130252936 - BURLI; Roland Werner ;   et al.
2013-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed